Thursday, Apr 25 2024 | Time 20:52 Hrs(IST)
image
Business Economy


Dr Reddy's Laboratories launches Neostigmine Methylsulfate Injection, USP in US Market

Dr Reddy's Laboratories launches Neostigmine Methylsulfate Injection, USP in US Market

Mumbai, Sep 13(UNI) Pharma Major, Dr Reddy's Laboratories Ltd announced the launch of Neostigmine Methylsulfate Injection, USP, a therapeutic equivalent generic version of Bloxiverz (Neostigmine Methylsulfate) Injection approved by the US Food and Drug Administration (USFDA).

The Bloxiverz brand and generic had US sales of approximately USD111 million MAT for the most recent twelve months ending in July 2018 according to IMS Health.

Dr Reddy's Neostigmine Methylsulfate Injection, USP is available in 5 mg/10 ml and 10 mg/10 ml multi-dose vials.

Bloxiverz is a registered trademark of Avadel Legacy Pharmaceuticals LLC.

UNI JS RSU 1603

More News

Tech Mahindra net at Rs 661 crore in Q4; Company gives dividend of Rs 28 per share

25 Apr 2024 | 7:28 PM

New Delhi, April 25 (UNI) Mahindra Group company Tech Mahindra, a technology consulting and digital solutions provider, on Thursday reported about 41 per cent decline in net profit at Rs 661 crore year-on-year basis for the fourth quarter ended March 31, 2024.

see more..

Kottayam-Kochi Rubber Market Rates

25 Apr 2024 | 7:26 PM

Kottayam, April 25 (UNI) Following were the Rubber Market rates announced by the Rubber Board here today per quintal.

see more..
Indusind Bank net up 15 pc in Q4

Indusind Bank net up 15 pc in Q4

25 Apr 2024 | 7:10 PM

New Delhi, April 25 (UNI) Leading private bank Indusind on Thursday reported a 15 percent jump in net profit at Rs 2,349 crore in Q4 of FY 2023–24, compared to Rs 2,043 crore in the same quarter in 2022–23.

see more..

25 Apr 2024 | 6:53 PM

New Delhi, April 25 (UNI) Leading private bank Indusind on Thursday reported 15 percent jump in net profit at Rs 2,349 crore in Q4 of FY 2023-24 compared to Rs 2,043 crore in the same quarter in 2022-23.

see more..

Regulations to become more stringent, demanding in coming years : CUB MD

25 Apr 2024 | 6:40 PM

Chennai, Apr 25 (UNI) “Regulations are going to be here, and they are going to
get more stringent as there is a learning depending upon the changes in the
environment and the role of the CFO's,” City Union Bank (CUB) MD and CEO
Dr N Kamakodi observed on Thursday.

see more..
image